Cognex Corporation (CGNX)
Official siteTECHNOLOGY • SCIENTIFIC & TECHNICAL INSTRUMENTS • NASDAQ
Market Cap: $8.12B
Last updated: Nov 17, 2026 at 4:36 PM ET
Cognex Corporation (CGNX) Statistics
Cognex (CGNX) has a market cap of $8.12B and an enterprise value of $7.42B. Its trailing P/E of 30.5x is below its 10-year median of 46.0x.
Total Valuation
Enterprise value is 8.56% below the market cap, as cash exceeds debt.
| Market Cap | $8.12B |
|---|---|
| Enterprise Value | $7.42B |
| Latest price (Nov 17, 2026) | $48.50 |
Key Dates
The next earnings report is expected on Feb 9, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Nov 19, 2026.
| Next Earnings Date | Feb 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Next Ex-Dividend Date | Nov 19, 2026 |
| Next Payment Date | Dec 3, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 7.3x and 4.7x. Its year-end P/E ranged from 31.2x to 74.3x from 2016 to 2025.
| P/E Ratio | 30.5x |
|---|---|
| Forward P/E | 27.8x |
| P/S Ratio | 7.3x |
| Forward P/S | 7.0x |
| P/B Ratio | 4.7x |
| P/TBV Ratio | 6.4x |
| P/FCF Ratio | 28.5x |
| P/OCF Ratio | 27.5x |
| PEG Ratio | 1.1 |
Enterprise Valuation
Counting debt and cash, the company is valued at 24.2x EBITDA and 26.1x free cash flow.
| EV / Earnings | 30.7x |
|---|---|
| EV / Sales | 6.6x |
| EV / EBITDA | 24.2x |
| EV / FCF | 26.1x |
Price Statistics
The stock is up 32.10% over 52 weeks and trades 15.70% below its 50-day average.
| Beta (1Y) | 1.84 |
|---|---|
| 52-Week Change | +32.10% |
| 1-Month Change | -12.07% |
| 3-Month Change | -19.91% |
| 6-Month Change | -19.81% |
| 5-Year Change | -35.89% |
| 10-Year Change | +117.64% |
| Total Return (1Y) | +32.80% |
| Total Return (3Y CAGR) | +10.02% |
| Total Return (5Y CAGR) | -8.91% |
| Return vs SPY (1Y) | +23.73% |
| Max Drawdown (1Y) | -34.32% |
| Max Drawdown (3Y) | -55.74% |
| Sharpe Ratio (1Y) | 0.54 |
| Correlation with SPY (1Y) | 0.45 |
| 50-Day Average | $57.53 |
| 200-Day Average | $58.49 |
| 52-Week Range | $34.45 to $72.78 |
| RSI (14 Days) | 36.6 |
| Average Volume (20 Days) | 2.12M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.04x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 5.04x |
|---|---|
| Quick Ratio | 4.34x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 14.05% over the last 12 months, against a 5-year average of 11.35%.
| Return on Equity (ROE) | 14.05% |
|---|---|
| Return on Assets (ROA) | 10.63% |
| ROE (5Y Average) | 11.35% |
| ROA (5Y Average) | 8.32% |
| ROIC (5Y Average) | 7.23% |
| Asset Turnover | 0.53x |
| Inventory Turnover | 2.26x |
| Receivables Turnover | 4.91x |
| Cash Conversion Cycle | 161 days |
Taxes
Income tax took 18.93% of pretax income over the last 12 months.
| Income Tax (TTM) | $56.48M |
|---|---|
| Effective Tax Rate | 18.93% |
Scores
CGNX has an Altman Z-Score of 10.50, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 10.50 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.13B over the last 12 months is up 15.82% from the 12 months before.
| Revenue | $1.13B |
|---|---|
| Revenue Growth (YoY) | +15.82% |
| Gross Profit | $784.36M |
| Operating Income | $281.49M |
| Pretax Income | $298.43M |
| Net Income | $241.94M |
| EBITDA | $308.39M |
| Reported EPS (TTM) | $1.59 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 75.44% of the $2.28B in total assets.
| Cash and Equivalents | $694.70M |
|---|---|
| Total Debt | $0 |
| Net Cash | $694.70M |
| Net Cash Per Share | $4.13 |
| Working Capital | $923.12M |
| Shareholder Equity | $1.72B |
| Book Value Per Share | $10.23 |
| Tangible Book Value | $1.27B |
| Tangible Book Per Share | $7.56 |
| Total Assets | $2.28B |
| Total Liabilities | $554.98M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $9.52M of capital spending, operating cash flow left $286.04M of free cash flow.
| Operating Cash Flow | $295.56M |
|---|---|
| Capital Expenditures | $9.52M |
| Free Cash Flow | $286.04M |
| FCF Per Share | $1.70 |
| Depreciation and Amortization | $27.97M |
| Dividends Paid | $56.97M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 25.01%, against a 5-year average of 19.88%.
| Gross Margin | 69.69% |
|---|---|
| Operating Margin | 25.01% |
| Pretax Margin | 26.52% |
| Net Margin | 21.50% |
| EBITDA Margin | 27.40% |
| FCF Margin | 25.42% |
| Gross Margin (5Y Average) | 70.43% |
| Operating Margin (5Y Average) | 19.88% |
| Net Margin (5Y Average) | 17.01% |
Growth
Revenue fell 0.39% a year over 3 years, and EPS 8.30% a year.
| Revenue Growth (3Y CAGR) | -0.39% |
|---|---|
| Revenue Growth (5Y CAGR) | +4.16% |
| EPS Growth (3Y CAGR) | -8.30% |
| EPS Growth (5Y CAGR) | -1.33% |
| FCF Growth (3Y CAGR) | +1.91% |
| FCF Growth (5Y CAGR) | +0.66% |
| Operating Income Growth (3Y CAGR) | -12.92% |
| Book Value Per Share Growth (2Y CAGR) | +0.65% |
| Tangible Book Per Share Growth (2Y CAGR) | +2.38% |
Dividends and Yields
CGNX pays out 14.52% of earnings as dividends.
| Dividend Per Share (Annual) | $0.34 |
|---|---|
| Dividend Yield | 0.70% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +7.04% |
| Dividend Growth (5Y CAGR) | +7.63% |
| Payout Ratio | 14.52% |
| FCF Payout Ratio | 19.92% |
| Earnings Yield | 3.28% |
| FCF Yield | 3.50% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 0.60% |
Stock Splits
The last split was a 2-for-1 forward split on Dec 4, 2017.
| Last Split Date | Dec 4, 2017 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 11 similar companies, CGNX has the 4th highest P/E and the 2nd highest P/S.
P/E RatioPeer median 21.2x
P/S RatioPeer median 4.5x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +12.78%
Dividend YieldPeer median 0.07%
| P/E Ratio | 30.5x vs 21.2x median |
|---|---|
| P/S Ratio | 7.3x vs 4.5x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +15.82% vs +12.78% median |
| Dividend Yield | 0.70% vs 0.07% median |
Analyst Forecast
Consensus estimates put revenue growth at 13.64% and EPS growth at 41.02% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +13.64% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +41.02% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CGNX
What is CGNX's market cap?
Cognex has a market cap of $8.12B. Its enterprise value, which adds debt and subtracts cash, is $7.42B.
What is CGNX's P/E ratio?
Cognex has a trailing P/E ratio of 30.5x and a forward P/E of 27.8x.
How many shares of CGNX are outstanding?
Cognex has 168.31M shares outstanding. The count is up 0.28% from a year earlier.
Does CGNX pay a dividend?
Yes. Cognex pays $0.34 a share a year, a dividend yield of 0.70%.
How much debt does CGNX have?
Cognex has $0 of total debt and $694.70M of cash and equivalents, a net cash position of $694.70M.
CGNX pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors